2-(Bromomethyl)-1H-imidazole

Catalog No.: 
ACJEVN947
CAS No.: 
735273-40-2
Molecular Formula: 
C4H5BrN2
Molecular Weight: 
161.00
2-(Bromomethyl)-1H-imidazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$77.00InquiryInquiry
1g95%$194.00InquiryInquiry
5g95%$664.00InquiryInquiry
10g95%$1104.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(Bromomethyl)-1H-imidazole
IUPAC Name2-(bromomethyl)-1H-imidazole
MDL No.MFCD09842488
Molecular FormulaC4H5BrN2
Molecular Weight161.00
SMILESBrCC1=NC=CN1
InChI KeyJMIPWQWATHJTMZ-UHFFFAOYSA-N
Synonym2-(Bromomethyl)imidazole;2-(Bromomethyl)-1H-imidazole;2-(Bromomethyl)imidazole HBr;1H-IMidazole,2-(broMoMethyl)-
CAS No.735273-40-2

Safety Data

Pictogram
CorrosiveHarmful or irritant
Signal Word
Danger
Hazard Statement(s)
H302-H314
Precautionary Statement(s)
P260-P264-P270-P280-P301+P330+P331-P303+P361+P353-P304+P340-P305+P351+P338-P310-P363-P405-P501

Synthetic Route by SureRoute

1. ACJEVN947 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACRAEP931 route compound structure diagram
    ACRAEP931116177-22-1
  4. Then
  5. ACJEVN947 route product structure diagram
    ACJEVN947735273-40-2
Inquiry

2. ACJEVN947 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCNFA526 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACJEVN947 route product structure diagram
    ACJEVN947735273-40-2
Inquiry

3. ACJEVN947 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACCNFA526 route compound structure diagram
    --
  4. Then
  5. ACJEVN947 route product structure diagram
    ACJEVN947735273-40-2
Inquiry

Comments (0)